SPIRIVA RESPIMAT for COPD doctor discussion guide

Conversation starters for you and your doctor

When you've answered the questions below, print your results or email them to yourself and bring them to your next doctor's appointment.

Try Again

  1. How often do you use a rescue inhaler?

  2. Do you find yourself experiencing breathing difficulties more frequently than you used to?

  3. Have you found yourself short of breath or coughing more often over the past 6 months?

  4. Are you less active than you were a year ago because of your breathing?

Use these tips to start the conversation with your doctor:

  • Be open with concerns you have. Don’t be afraid to tell your doctor if you’re worried about your health
  • Be honest about health habits. Even if you have bad habits—smoking, eating poorly—tell your doctor, so you can get the best possible treatment
  • Don’t be embarrassed. Ask about anything you don’t understand. It’s better for you and your doctor if you understand everything completely
  • Be clear. Avoid descriptions like "I don’t feel right." Be specific: "I’m more short of breath than I was last week"
  • Follow up. Pick up medications on the way home. Write down new information. Consider sharing information with a loved one

Sign up to receive your SPIRIVA RESPIMAT for COPD discussion guide via email

Plus, get access to ongoing helpful information about COPD and SPIRIVA

To send your discussion guide answers to your email address, just enter your information below. In addition, an email reminder of your discussion guide results will be sent closer to your next doctor’s appointment.

All fields required unless noted as optional.

Please complete all required fields

First name:

Last name:

Email address:

Zip code (five digits only):

Have you been diagnosed with COPD?

Has your doctor prescribed SPIRIVA RESPIMAT for you?

Next doctor’s appointment:

Estimate how long until you see your doctor again

Yes! I allow Boehringer Ingelheim Pharmaceuticals, Inc. and companies working on its behalf to use this information to contact me about health- and product-related information and services associated with SPIRIVA RESPIMAT and other products.

Check the box if you agree to allow us, and companies working on our behalf, to use your information in this manner.

IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT (tiotropium bromide) Inhalation Spray and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT and SPIRIVA HANDIHALER (continued)

Do not use SPIRIVA RESPIMAT or SPIRIVA HANDIHALER if you are allergic to tiotropium, ipratropium, atropine or similar drugs, or any ingredient in these medicines.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER are not rescue medicines and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause allergic reactions. Symptoms can include raised red patches on your skin (hives), itching, rash and/or swelling of the lips, tongue, or throat that may cause difficulty in breathing or swallowing. If you have any of these symptoms, stop taking the medicine and seek emergency medical care.

Before using SPIRIVA HANDIHALER, tell your doctor if you have a severe allergy to milk proteins.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause your breathing to suddenly get worse (bronchospasm). If this happens, use your rescue inhaler, stop taking SPIRIVA, and call your doctor right away or seek emergency medical care.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can increase the pressure in your eyes (acute narrow-angle glaucoma) which can cause the following symptoms: eye pain, blurred vision, seeing halos or colored images along with red eyes. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

Dizziness and blurred vision may occur with SPIRIVA RESPIMAT or SPIRIVA HANDIHALER. If you experience these symptoms, use caution when engaging in activities such as driving a car, or operating appliances or machinery.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause new or worsened urinary retention. Symptoms of blockage in your bladder and/or enlarged prostate may include difficulty passing urine and/or painful urination. If you have any of these symptoms, stop taking your medicine and call your doctor right away.

The most common side effects reported with SPIRIVA RESPIMAT in patients with COPD include sore throat, cough, dry mouth, and sinus infection.

The most common side effects with SPIRIVA RESPIMAT in adult patients with asthma were sore throat, headache, bronchitis, and sinus infection. The side effect profile for adolescent and pediatric patients was comparable to that observed in adult patients with asthma.

The most common side effects reported with SPIRIVA HANDIHALER in patients with COPD include upper respiratory tract infection, dry mouth, sinus infection, sore throat, non-specific chest pain, urinary tract infection, indigestion, runny nose, constipation, increased heart rate, and blurred vision.

Do not swallow SPIRIVA capsules. The contents of the capsule should only be inhaled through your mouth using the HANDIHALER device.

Do not spray SPIRIVA RESPIMAT into your eyes, as this may cause blurring of vision and pupil dilation.

Tell your doctor about all your medical conditions including kidney problems, glaucoma, enlarged prostate, problems passing urine, or blockage in your bladder.

Tell your doctor all the medicines you take, including eye drops. Ask your doctor if you are taking any anticholinergic medicines because taking them together with SPIRIVA can increase side effects. Do not use SPIRIVA RESPIMAT and SPIRIVA HANDIHALER together.

INDICATIONS for SPIRIVA RESPIMAT (tiotropium bromide) and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

SPIRIVA RESPIMAT, 2.5 mcg, and SPIRIVA HANDIHALER are long-term, once-daily, prescription maintenance medicines used to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing your airways and keeping them open. COPD includes chronic bronchitis and emphysema. SPIRIVA RESPIMAT and SPIRIVA HANDIHALER also reduce the likelihood of flare-ups (COPD exacerbations).

SPIRIVA RESPIMAT, 1.25 mcg, is a long-term, once-daily, prescription maintenance treatment of asthma for people 6 years and older.

SPIRIVA is not a treatment for sudden symptoms of asthma or COPD.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information for SPIRIVA RESPIMAT, including Instructions for Use, and full Prescribing Information for SPIRIVA HANDIHALER, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION for STIOLTO RESPIMAT (continued)
IMPORTANT SAFETY INFORMATION for SPIRIVA RESPIMAT (tiotropium bromide) and SPIRIVA HANDIHALER (tiotropium bromide inhalation powder)

Do not use SPIRIVA RESPIMAT or SPIRIVA HANDIHALER if you are allergic to tiotropium, ipratropium, atropine or similar drugs, or any ingredient in these medicines.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER are not rescue medicines and should not be used for treating sudden breathing problems. Your doctor may give you other medicine to use for sudden breathing problems.

SPIRIVA RESPIMAT or SPIRIVA HANDIHALER can cause allergic reactions. Symptoms can include raised red patches on your skin (hives), itching, rash and/or swelling of the lips, tongue, or throat that may cause difficulty in breathing or swallowing. If you have any of these symptoms, stop taking the medicine and seek emergency medical care.